The Global Virus Network

Challenging chikungunya

Edward McSweegan, Scott Weaver, Marc Lecuit, Matthew Frieman, Thomas E. Morrison, Sharon Hrynkow

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Abstract The recent spread of chikungunya virus to the Western Hemisphere, together with the ongoing Ebola epidemic in West Africa, have highlighted the importance of international collaboration in the detection and management of disease outbreaks. In response to this need, the Global Virus Network (GVN) was formed in 2011. The GVN is a coalition of leading medical virologists in 34 affiliated laboratories in 24 countries, who collaborate to share their resources and expertise. The GVN supports research, promotes training for young scientists, serves as a technical resource for governments, businesses and international organizations, facilitates international scientific cooperation, and advocates for funding and evidence-based public policies. In response to the spread of chikungunya, the GVN formed a task force to identify research gaps and opportunities, including models of infection and disease, candidate vaccines and antivirals, epidemiology and vector control measures. Its members also serve as authoritative sources of information for the public, press, and policy-makers. This article forms part of a symposium in Antiviral Research on "Chikungunya discovers the New World".

Original languageEnglish (US)
Article number3643
Pages (from-to)147-152
Number of pages6
JournalAntiviral Research
Volume120
DOIs
StatePublished - Jun 23 2015
Externally publishedYes

Fingerprint

Chikungunya virus
Public Policy
Viruses
Antiviral Agents
Research
International Cooperation
Western Africa
Advisory Committees
Administrative Personnel
Disease Outbreaks
Epidemiology
Vaccines
Organizations
Infection

Keywords

  • Arbovirus
  • Chikungunya
  • Emerging virus
  • Global Virus Network
  • Vector-borne

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this

McSweegan, E., Weaver, S., Lecuit, M., Frieman, M., Morrison, T. E., & Hrynkow, S. (2015). The Global Virus Network: Challenging chikungunya. Antiviral Research, 120, 147-152. [3643]. https://doi.org/10.1016/j.antiviral.2015.06.003

The Global Virus Network : Challenging chikungunya. / McSweegan, Edward; Weaver, Scott; Lecuit, Marc; Frieman, Matthew; Morrison, Thomas E.; Hrynkow, Sharon.

In: Antiviral Research, Vol. 120, 3643, 23.06.2015, p. 147-152.

Research output: Contribution to journalArticle

McSweegan, E, Weaver, S, Lecuit, M, Frieman, M, Morrison, TE & Hrynkow, S 2015, 'The Global Virus Network: Challenging chikungunya', Antiviral Research, vol. 120, 3643, pp. 147-152. https://doi.org/10.1016/j.antiviral.2015.06.003
McSweegan E, Weaver S, Lecuit M, Frieman M, Morrison TE, Hrynkow S. The Global Virus Network: Challenging chikungunya. Antiviral Research. 2015 Jun 23;120:147-152. 3643. https://doi.org/10.1016/j.antiviral.2015.06.003
McSweegan, Edward ; Weaver, Scott ; Lecuit, Marc ; Frieman, Matthew ; Morrison, Thomas E. ; Hrynkow, Sharon. / The Global Virus Network : Challenging chikungunya. In: Antiviral Research. 2015 ; Vol. 120. pp. 147-152.
@article{1e42cf83ab9047fa8cd562507a23ba17,
title = "The Global Virus Network: Challenging chikungunya",
abstract = "Abstract The recent spread of chikungunya virus to the Western Hemisphere, together with the ongoing Ebola epidemic in West Africa, have highlighted the importance of international collaboration in the detection and management of disease outbreaks. In response to this need, the Global Virus Network (GVN) was formed in 2011. The GVN is a coalition of leading medical virologists in 34 affiliated laboratories in 24 countries, who collaborate to share their resources and expertise. The GVN supports research, promotes training for young scientists, serves as a technical resource for governments, businesses and international organizations, facilitates international scientific cooperation, and advocates for funding and evidence-based public policies. In response to the spread of chikungunya, the GVN formed a task force to identify research gaps and opportunities, including models of infection and disease, candidate vaccines and antivirals, epidemiology and vector control measures. Its members also serve as authoritative sources of information for the public, press, and policy-makers. This article forms part of a symposium in Antiviral Research on {"}Chikungunya discovers the New World{"}.",
keywords = "Arbovirus, Chikungunya, Emerging virus, Global Virus Network, Vector-borne",
author = "Edward McSweegan and Scott Weaver and Marc Lecuit and Matthew Frieman and Morrison, {Thomas E.} and Sharon Hrynkow",
year = "2015",
month = "6",
day = "23",
doi = "10.1016/j.antiviral.2015.06.003",
language = "English (US)",
volume = "120",
pages = "147--152",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",

}

TY - JOUR

T1 - The Global Virus Network

T2 - Challenging chikungunya

AU - McSweegan, Edward

AU - Weaver, Scott

AU - Lecuit, Marc

AU - Frieman, Matthew

AU - Morrison, Thomas E.

AU - Hrynkow, Sharon

PY - 2015/6/23

Y1 - 2015/6/23

N2 - Abstract The recent spread of chikungunya virus to the Western Hemisphere, together with the ongoing Ebola epidemic in West Africa, have highlighted the importance of international collaboration in the detection and management of disease outbreaks. In response to this need, the Global Virus Network (GVN) was formed in 2011. The GVN is a coalition of leading medical virologists in 34 affiliated laboratories in 24 countries, who collaborate to share their resources and expertise. The GVN supports research, promotes training for young scientists, serves as a technical resource for governments, businesses and international organizations, facilitates international scientific cooperation, and advocates for funding and evidence-based public policies. In response to the spread of chikungunya, the GVN formed a task force to identify research gaps and opportunities, including models of infection and disease, candidate vaccines and antivirals, epidemiology and vector control measures. Its members also serve as authoritative sources of information for the public, press, and policy-makers. This article forms part of a symposium in Antiviral Research on "Chikungunya discovers the New World".

AB - Abstract The recent spread of chikungunya virus to the Western Hemisphere, together with the ongoing Ebola epidemic in West Africa, have highlighted the importance of international collaboration in the detection and management of disease outbreaks. In response to this need, the Global Virus Network (GVN) was formed in 2011. The GVN is a coalition of leading medical virologists in 34 affiliated laboratories in 24 countries, who collaborate to share their resources and expertise. The GVN supports research, promotes training for young scientists, serves as a technical resource for governments, businesses and international organizations, facilitates international scientific cooperation, and advocates for funding and evidence-based public policies. In response to the spread of chikungunya, the GVN formed a task force to identify research gaps and opportunities, including models of infection and disease, candidate vaccines and antivirals, epidemiology and vector control measures. Its members also serve as authoritative sources of information for the public, press, and policy-makers. This article forms part of a symposium in Antiviral Research on "Chikungunya discovers the New World".

KW - Arbovirus

KW - Chikungunya

KW - Emerging virus

KW - Global Virus Network

KW - Vector-borne

UR - http://www.scopus.com/inward/record.url?scp=84934957173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934957173&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2015.06.003

DO - 10.1016/j.antiviral.2015.06.003

M3 - Article

VL - 120

SP - 147

EP - 152

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

M1 - 3643

ER -